Palucorcel
- Generic Name
- Palucorcel
- Drug Type
- Biotech
- Unique Ingredient Identifier
- 3T0UGR2M5Q
- Background
Palucorcel is an investigational stem cell therapy consisting of human umbilical tissue-derived cells. Developed by Janssen Biotech, it is being investigated for the treatment of various conditions such as amyotrophic lateral sclerosis (ALS) and macular degeneration.
A Study to Evaluate the Safety of CNTO 2476 in Patients With Advanced Retinitis Pigmentosa
- First Posted Date
- 2007-04-11
- Last Posted Date
- 2014-06-26
- Lead Sponsor
- Centocor, Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT00458575
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath